![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 49, 38363-38370, December 8, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Cell Biology, The Lerner Research Institute,
Cleveland Clinic Foundation, Cleveland, Ohio 44195 and
§ Departments of Growth Development and Anatomy, Programs in
Cell Biology and Developmental Biology, University of California at San
Francisco, San Francisco, California 94143-0640
Transforming growth factor-
Smad7 Is Induced by CD40 and Protects WEHI 231 B-lymphocytes
from Transforming Growth Factor-
-induced Growth Inhibition and
Apoptosis*
,
(TGF-
) is a
potent inducer of apoptosis in B-lymphocytes and is essential for
immune regulation and maintenance of self-tolerance. Here we show that
concomitant signaling through CD40 sustains proliferation and rescues
the premature B cell line WEHI 231 from both TGF-
-induced and
anti-IgM-induced apoptosis. The anti-apoptotic effect of CD40 is
associated with the transcriptional activation of the inhibitory Smad7
protein. The transactivation of Smad7 by CD40 is
NF
B-dependent in that pharmacological inhibitors of this
pathway, N-tosyl-L-phenylalanine chloromethyl
ketone and pyrrolidine dithiocarbamate, abrogate CD40-induced Smad7
expression. Ectopic overexpression of Smad7 inhibited Smad2 activation,
TGF-
-mediated growth inhibition, and apoptosis in WEHI 231 cells.
Consistent with this result, dominant negative interference with Smad2
and Smad3 function also inhibited TGF-
-induced apoptosis. The
inhibitory effects of Smad7 overexpression were specific to
TGF-
-induced apoptosis and were without effect on anti-IgM-induced
cell death. These results suggest a mechanism of suppression of
TGF-
-induced apoptosis by CD40, mediated through activation of
NF-
B and, consequently, induction of Smad7 expression.
*
This work was supported by National Institutes of Health
Grants CA80095 (NCI) (to P. H. H.) and P01-HL60231 (project III) (to
R. D.) and a postdoctoral fellowship from the American Heart Association (to L. C.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Dept. of Physiology and Biophysics, School of
Medicine, MM-12, Wright State University, 3640 Colonel Glenn Highway,
Dayton, OH 45435-0001.
¶
To whom correspondence should be addressed: Dept. of Cell
Biology, NC1, The Lerner Research Institute, Cleveland Clinic
Foundation, Cleveland, OH 44195. Tel.: 216- 445-9750; Fax:
216-445-7855; E-mail: howep@ccf.org.
This article has been cited by other articles:
![]() |
T. L. Criswell and C. L. Arteaga Modulation of NF{kappa}B Activity and E-cadherin by the Type III Transforming Growth Factor beta Receptor Regulates Cell Growth and Motility J. Biol. Chem., November 2, 2007; 282(44): 32491 - 32500. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Li, A. Rosendahl, G. Brodin, A. M. Cheng, A. Ahgren, C. Sundquist, S. Kulkarni, T. Pawson, C.-H. Heldin, and R. L. Heuchel Deletion of Exon I of SMAD7 in Mice Results in Altered B Cell Responses. J. Immunol., June 1, 2006; 176(11): 6777 - 6784. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pasche, T. J. Knobloch, Y. Bian, J. Liu, S. Phukan, D. Rosman, V. Kaklamani, L. Baddi, F. S. Siddiqui, W. Frankel, et al. Somatic Acquisition and Signaling of TGFBR1*6A in Cancer JAMA, October 5, 2005; 294(13): 1634 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Huan, D. Sashital, T. Hailemariam, M. L. Kelly, and C. A. J. Roman Renal Carcinoma-associated Transcription Factors TFE3 and TFEB Are Leukemia Inhibitory Factor-responsive Transcription Activators of E-cadherin J. Biol. Chem., August 26, 2005; 280(34): 30225 - 30235. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chadwick, F. Shojaei, L. Gallacher, and M. Bhatia Smad7 alters cell fate decisions of human hematopoietic repopulating cells Blood, March 1, 2005; 105(5): 1905 - 1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Undevia, D. R. Dorscheid, B. A. Marroquin, W. L. Gugliotta, R. Tse, and S. R. White Smad and p38-MAPK signaling mediates apoptotic effects of transforming growth factor-{beta}1 in human airway epithelial cells Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L515 - L524. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, M. P. Keane, L. X. Zhu, S. Sharma, E. Rozengurt, R. M. Strieter, S. M. Dubinett, and M. Huang Interleukin-7 and Transforming Growth Factor-{beta} Play Counter-regulatory Roles in Protein Kinase C-{delta}-dependent Control of Fibroblast Collagen Synthesis in Pulmonary Fibrosis J. Biol. Chem., July 2, 2004; 279(27): 28315 - 28319. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sarkar, E. Vellaichamy, D. Young, and S. Sen Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H107 - H117. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Rendi, N. Suh, W. W. Lamph, S. Krajewski, J. C. Reed, R. A. Heyman, A. Berchuck, K. Liby, R. Risingsong, D. B. Royce, et al. The Selective Estrogen Receptor Modulator Arzoxifene and the Rexinoid LG100268 Cooperate to Promote Transforming Growth Factor {beta}-Dependent Apoptosis in Breast Cancer Cancer Res., May 15, 2004; 64(10): 3566 - 3571. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Kim, H.-S. Jong, T.-Y. Kim, J. W. Lee, N. K. Kim, S. H. Hong, and Y.-J. Bang Transforming Growth Factor-{beta}1 Induces Apoptosis through Fas Ligand-independent Activation of the Fas Death Pathway in Human Gastric SNU-620 Carcinoma Cells Mol. Biol. Cell, February 1, 2004; 15(2): 420 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, C. Dai, and Y. Liu Hepatocyte Growth Factor Suppresses Renal Interstitial Myofibroblast Activation and Intercepts Smad Signal Transduction Am. J. Pathol., August 1, 2003; 163(2): 621 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Roes, B. K. Choi, and B. B. Cazac Redirection of B cell responsiveness by transforming growth factor {beta} receptor PNAS, June 10, 2003; 100(12): 7241 - 7246. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Wildey, S. Patil, and P. H. Howe Smad3 Potentiates Transforming Growth Factor beta (TGFbeta )-induced Apoptosis and Expression of the BH3-only Protein Bim in WEHI 231 B Lymphocytes J. Biol. Chem., May 9, 2003; 278(20): 18069 - 18077. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Coyle, C. Freathy, T. W. Gant, R. A. Roberts, and K. Cain Characterization of the Transforming Growth Factor-beta 1-induced Apoptotic Transcriptome in FaO Hepatoma Cells J. Biol. Chem., February 14, 2003; 278(8): 5920 - 5928. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kanamaru, H. Yasuda, M. Takeda, N. Ueda, J. Suzuki, T. Tsuchida, H. Mashima, H. Ohnishi, and T. Fujita Smad7 Is Induced by Norepinephrine and Protects Rat Hepatocytes from Activin A-induced Growth Inhibition J. Biol. Chem., November 30, 2001; 276(49): 45636 - 45641. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |